Peter J. O’Dwyer
- Oncology top 0.05%
- Molecular Biology top 0.2%
- Pulmonary and Respiratory Medicine top 0.2%
- Cancer Research top 0.2%
- Immunology top 0.5%
- Co-authors
- Keith T. FlahertyAl B. BensonPaul J. CatalanoBruce J. GiantonioEdith P. MitchellK. B. NolopSteven R. AlbertsJeffrey A. Sosman
- Topics
- Colorectal Cancer Treatments and Studies (93 papers)Cancer Treatment and Pharmacology (56 papers)Pancreatic and Hepatic Oncology Research (55 papers)
- Cited by
- OncologyCancer ResearchHepatology
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Peter J. O’Dwyer
389 papers receiving 23.0k citations
Hit Papers
Peers
Comparison fields: 5 of 173
- Oncology 13.0k
- Molecular Biology 9.9k
- Pulmonary and Respiratory Medicine 5.2k
- Cancer Research 3.9k
- Immunology 2.9k
Countries citing papers authored by Peter J. O’Dwyer
This map shows the geographic impact of Peter J. O’Dwyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. O’Dwyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. O’Dwyer more than expected).
Fields of papers citing papers by Peter J. O’Dwyer
This network shows the impact of papers produced by Peter J. O’Dwyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. O’Dwyer. The network helps show where Peter J. O’Dwyer may publish in the future.
Co-authorship network of co-authors of Peter J. O’Dwyer
This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. O’Dwyer. A scholar is included among the top collaborators of Peter J. O’Dwyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. O’Dwyer. Peter J. O’Dwyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 35 | |
| 6 | 23 | |
| 7 | 16 | |
| 8 | 31 | |
| 9 | Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancerbreakdown → | 513 |
| 10 | 22 | |
| 11 | 280 | |
| 12 | 182 | |
| 13 | 69 | |
| 14 | 364 | |
| 15 | 54 | |
| 16 | 295 | |
| 17 | 118 | |
| 18 | Phase II Trial of Sorafenib in Advanced Thyroid Cancerbreakdown → | 535 |
| 19 | 416 | |
| 20 | Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinomabreakdown → | 794 |
About Peter J. O’Dwyer
Peter J. O’Dwyer is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 401 papers that have together received 23.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (93 papers), Cancer Treatment and Pharmacology (56 papers) and Pancreatic and Hepatic Oncology Research (55 papers). The work is most often cited by research in Oncology (13.0k citations), Cancer Research (3.9k citations) and Hepatology (1.4k citations). Peter J. O’Dwyer has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Keith T. Flaherty, Al B. Benson, Paul J. Catalano, Bruce J. Giantonio, Edith P. Mitchell, K. B. Nolop, Steven R. Alberts, Jeffrey A. Sosman, Richard J. Lee and Grant A. McArthur. Their work appears in journals such as Science, New England Journal of Medicine and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.